These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33774344)

  • 1. Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide.
    Wang X; Wu K; Fang L; Yang X; Zheng N; Du Z; Lu Y; Xie Z; Liu Z; Zuo Z; Ye F
    Eur J Med Chem; 2021 Jun; 218():113362. PubMed ID: 33774344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3).
    Chen H; Yang Z; Ding C; Xiong A; Wild C; Wang L; Ye N; Cai G; Flores RM; Ding Y; Shen Q; Zhou J
    Eur J Med Chem; 2014 Jul; 82():195-203. PubMed ID: 24904966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer.
    Wu MM; Zhang Z; Tong CWS; Yan VW; Cho WCS; To KKW
    Life Sci; 2020 Dec; 262():118522. PubMed ID: 33011217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway.
    Zhu Y; Zuo W; Chen L; Bian S; Jing J; Gan C; Wu X; Liu H; Su X; Hu W; Guo Y; Wang Y; Ye T
    Biochem Pharmacol; 2019 Nov; 169():113610. PubMed ID: 31465777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based discovery of potent and selective small-molecule inhibitors targeting signal transducer and activator of transcription 3 (STAT3).
    Huang Q; Zhong Y; Li B; Ouyang S; Deng L; Mo J; Shi S; Lv N; Wu R; Liu P; Hu W; Zhang X; Wang Y
    Eur J Med Chem; 2021 Oct; 221():113525. PubMed ID: 34000483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Li Y
    Eur J Med Chem; 2013 Apr; 62():301-10. PubMed ID: 23376248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
    Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Ding N; Zhang W; Li Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors.
    Gao D; Jin N; Fu Y; Zhu Y; Wang Y; Wang T; Chen Y; Zhang M; Xiao Q; Huang M; Li Y
    Eur J Med Chem; 2021 Apr; 216():113333. PubMed ID: 33689932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF promotes HIF-1α expression in colorectal cancer cells and tumor metastasis by regulating phosphorylation of STAT3.
    Zhao FL; Qin CF
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1055-1062. PubMed ID: 30779072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3.
    Wang X; He Q; Wu K; Guo T; Du X; Zhang H; Fang L; Zheng N; Zhang Q; Ye F
    Eur J Med Chem; 2019 Oct; 179():218-232. PubMed ID: 31254923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery, synthesis, and evaluation of small-molecule signal transducer and activator of transcription 3 inhibitors.
    Shi ZB; Zhao D; Huang YY; Du Y; Cao XR; Gong ZN; Zhao R; Li JX
    Chem Pharm Bull (Tokyo); 2012; 60(12):1574-80. PubMed ID: 23207637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
    Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors.
    Furtek SL; Matheson CJ; Backos DS; Reigan P
    Oncotarget; 2016 Nov; 7(47):77998-78008. PubMed ID: 27793003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 4-methoxy-N-(1-naphthyl)benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751.
    Wang X; Lu Y; Sun D; Qian J; Tu S; Yue W; Lin H; Tang H; Meng F; He Q; Xie Z; Zhang Y; Chen H; Ma S; Zuo Z; Ye F
    Bioorg Chem; 2022 Aug; 125():105864. PubMed ID: 35584606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Activity of Novel Signal Transducer and Activator of Transcription 3 Inhibitors on Retinoblastoma.
    Jo DH; Lee S; Bak E; Cho CS; Han YT; Kim K; Suh YG; Kim JH
    Mol Pharmacol; 2021 Jul; 100(1):63-72. PubMed ID: 34016717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Arylsulfonylsubstituted-1H indole derivatives as small molecule dual inhibitors of signal transducer and activator of transcription 3 (STAT3) and tubulin.
    Zhou Q; Zhu J; Chen J; Ji P; Qiao C
    Bioorg Med Chem; 2018 Jan; 26(1):96-106. PubMed ID: 29174507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on BBI608 for cancer therapy.
    Feng KR; Wang F; Shi XW; Tan YX; Zhao JY; Zhang JW; Li QH; Lin GQ; Gao D; Tian P
    Eur J Med Chem; 2020 Sep; 201():112428. PubMed ID: 32603980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
    Liu C; Lou W; Armstrong C; Zhu Y; Evans CP; Gao AC
    Prostate; 2015 Sep; 75(13):1341-53. PubMed ID: 25970160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Structure-Activity Relationship Studies of Meridianin Derivatives as Novel JAK/STAT3 Signaling Inhibitors.
    Zhang JQ; Li R; Dong XY; He N; Yin RJ; Yang MK; Liu JY; Yu RL; Zhao CY; Jiang T
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.